2020 National Adult and Influenza Immunization Summit Virtual Meetings

The 2020 in-person Summit meeting was cancelled in response to COVID-19 recommendations. In its place, the Summit has sponsored a series of virtual meetings on topics of interest related to COVID-19 and its impact on immunization programs. Select a meeting title listed below to view a recording of each event, access individual presentations shared during the meeting, or review questions and answers provided by the presenters.

Be sure to check back on this page for announcements about upcoming webinars.


Developing COVID-19 Vaccines in Record Time, Part 2: Status of Clinical Trials
September 9, 2020 (12:00-2:00pm CT) (1:00-3:00pm ET)

At this follow-up to the National Adult and Influenza Immunization Summit (NAIIS) May 2nd virtual meeting on COVID-19 vaccines, we are inviting as many as 9 companies to present their latest clinical trial data. We will feature presentations from companies with COVID-19 vaccine candidates in later clinical trial phases (Phase 2/3) as well vaccines in earlier phases of clinical development. We are asking all companies to present on their clinical data, explain their technologies, provide information, as available, regarding vaccine storage and handling, and information on timelines for clinical trials that are ongoing or planned for the near future.

This meeting will be moderated by Phyllis Arthur, Vice President, Infectious Diseases & Diagnostics Policy, at BIO. We at the Summit are delighted and grateful for this opportunity to collaborate with BIO on this important virtual meeting.

Please register as soon as possible, registration will be closed at 4pm on September 8th. The webinar is open to all NAIIS members. All registrations will need to be reviewed and approved prior to confirmation of registration.


Impact of COVID-19 on Adult Immunization Coverage Rates and Update from CDC on Influenza Communications for 2020–21
July 30, 2020

Although the data showing the dramatic impact of COVID-19 in reducing routine pediatric immunization coverage rates are clear, less information has been available on adult immunization. At this virtual meeting, a panel of 6 vaccine manufacturers presented their data on the impact of COVID-19 on adult immunization coverage rates in the United States and internationally. The presenters also included information on potential directions they plan to take in the fall to address the steep declines in adult immunization coverage rates that have been observed. In addition to this panel, Becton-Dickinson provided information on their ongoing work to ensure a stable supply chain of syringes and needles this fall, and CDC presented on their communications plans for the upcoming influenza season.


Influenza Prevention in the Era of COVID-19
May 21, 2020

This informative event mirrored the typical final day of the in-person Summit, which was cancelled for 2020 due to COVID-19 transmission. Topics covered included influenza plans and reports from CDC, as well as updates from Summit partner organizations and influenza vaccine manufacturers.


Developing COVID-19 Vaccines in Record Time
May 12, 2020

During this virtual meeting, panel members discussed the path to COVID-19 vaccine clinical trials and shared their thoughts on how collaboration will bring life-saving vaccines to the world in this time of unprecedented need.